Qingdao Xingsai Biotechnology

Qingdao Xingsai Biotechnology

A developer of single-cell analysis instruments and supporting reagents and consumables.

Launch date
Employees
Market cap
-
Enterprise valuation
$55—83m (Dealroom.co estimates Dec 2023.)
Qingdao Shandong (HQ)
Authorizing premium user...